Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BJH

Crystal structure of neutralizing human monoclonal antibody 75C8 in complex with AMA1 DI-DII

9BJH の概要
エントリーDOI10.2210/pdb9bjh/pdb
分子名称Apical membrane antigen 1, 75C8 Fab Heavy Chain, 75C8 Fab Light Chain, ... (4 entities in total)
機能のキーワードapical membrane antigen 1, ama1, plasmodium, malaria, antigen-antibody complex, structural protein
由来する生物種Plasmodium falciparum 3D7
詳細
タンパク質・核酸の鎖数6
化学式量合計179002.24
構造登録者
Patel, P.N.,Tang, W.K.,Tolia, N.H. (登録日: 2024-04-25, 公開日: 2025-03-12, 最終更新日: 2025-04-02)
主引用文献Patel, P.N.,Diouf, A.,Dickey, T.H.,Tang, W.K.,Hopp, C.S.,Traore, B.,Long, C.A.,Miura, K.,Crompton, P.D.,Tolia, N.H.
A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade.
Cell Rep Med, 6:101985-101985, 2025
Cited by
PubMed Abstract: Plasmodium falciparum apical membrane antigen 1 (AMA1) binds a loop in rhoptry neck protein 2 (RON2L) during red cell invasion and is a target for vaccines and therapeutic antibodies against malaria. Here, we report a panel of AMA1-specific naturally acquired human monoclonal antibodies (hmAbs) derived from individuals living in malaria-endemic regions. Two neutralizing hmAbs engage AMA1 independent of the RON2L-binding site. The hmAb 75B10 demonstrates potent strain-transcending neutralization that is independent of RON2L blockade, emphasizing that epitopes outside the RON2L-binding site elicit broad protection against variant parasite strains. The combination of these hmAbs synergistically enhances parasite neutralization. Vaccination with a structure-based design (SBD1) that mimics the AMA1-RON2L complex elicited antibodies similar to the two neutralizing hmAbs connecting vaccination to naturally acquired immunity in humans. The structural definition of a strain-transcending epitope on AMA1 targeted by naturally acquired hmAb establishes paradigms for developing AMA1-based vaccines and therapeutic antibodies.
PubMed: 40020675
DOI: 10.1016/j.xcrm.2025.101985
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.8 Å)
構造検証レポート
Validation report summary of 9bjh
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon